PromaCare-TA / Tranexamic Acid

Sawirka Lagu Soo Bandhigay PromaCare-TA / Tranexamic Acid
  • PromaCare-TA / Tranexamic Acid

Sharaxaad Gaaban:

PromaCare-TA waa daawo guud, waana wakiil muhiim u ah antifibrinolytic liiska WHO. Waxaa loo isticmaalay daawo dhaqameed oo hemostatic ah. Waa daawo loogu talagalay in lagu joojiyo plasminogen ilaa plasmin dhiigga. Tranexamic acid si tartan ah ayuu u joojiyaa kicinta plasminogen (iyada oo loo marayo ku xidhka domainka kringle), taasoo yaraynaysa beddelka plasminogen una beddelaya plasmin (fibrinolysin), ensaym kaas oo burburiya xinjirooyinka fibrin, fibrinogen, iyo borotiinnada kale ee plasma, oo ay ku jiraan qodobbada procoagulant V iyo VIII. Tranexamic acid sidoo kale si toos ah ayuu u joojiyaa dhaqdhaqaaqa plasmin, laakiin qiyaaso ka badan ayaa loo baahan yahay si loo yareeyo sameynta plasmin.


Faahfaahinta Badeecada

Calaamadaha Alaabta

 

Magaca ganacsiga PromaCare-TA
CAS 1197-18-8
Magaca Badeecada Tranexamic Acid
Qaab-dhismeedka Kiimikada
Codsiga Daawo
Xirmo 25kgs shabaq durbaankiiba
Muuqaalka Cad ama ku dhawaad ​​​​caddaan, awood kiristaal ah
Baaritaan 99.0-101.0%
Milmida Biyo milma
Muddada khaanadaha 4 sano
Kaydinta Weelka si adag u xidh oo dhig meel qabow. Ka fogow kulaylka.

Codsiga

Tranexamic Acid, oo sidoo kale loo yaqaan xinjirowga dhiigga, waa amino acid ka hortagga fibrinolytic, kaas oo ka mid ah daawooyinka xinjirowga dhiigga ee sida caadiga ah loo isticmaalo kiliinikada.

Badeecadan waxaa loo isticmaali karaa:

1. Dhaawac ama dhiigbax qalliin ah oo ka yimaada qanjirka 'prostate', kaadi mareenka, sambabada, maskaxda, ilmo galeenka, qanjirka 'adrenal', qanjirka 'thyroid', beerka iyo xubno kale oo hodan ku ah firfircoonida 'plasminogen'.

2. Waxaa loo isticmaalaa sidii wakiilo thrombolytic ah, sida firfircoonida unugyada plasminogen (t-PA), streptokinase iyo urokinase antagonist.

3. Ilmo soo ridid, xoqidda mandheerta, dhalashada meydka iyo xinjirowga dareeraha amniotic-ga oo ay keento dhiig-baxa fibrinolytic.

4. Dhiig-baxa qaybta hore ee maskaxda (Menorrhagia), dhiig-baxa qaybta hore iyo barar daran oo ku dhaca xuubka maskaxda (epistaxis) oo ay weheliso fibrinolysis-ka maxalliga ah oo kordha.

5. Waxaa loo isticmaalaa in lagu hortago ama lagu yareeyo dhiigbaxa ka dib soo saarista ilkaha ama qalliinka afka ee bukaanada qaba hemophilic oo qaba yaraanta factor VIII ama factor IX.

6. Badeecadani waxay ka sarraysaa daawooyinka kale ee lidka ku ah fibrinolytic ee hemostasis-ka dhiig-baxa khafiifka ah ee ay keento dillaaca aneurysm-ka dhexe, sida dhiig-baxa subarachnoid iyo dhiig-baxa aneurysm-ka intracranial. Si kastaba ha ahaatee, waa in fiiro gaar ah loo yeesho khatarta bararka maskaxda ama wadne-istaagga maskaxda. Marka laga hadlayo bukaanada daran ee leh calaamado qalliin, badeecadan waxaa loo isticmaali karaa oo keliya sidii kaaliye.

7. Daaweynta bararka xididdada dhiigga ee dhaxalka ah, waxay yareyn kartaa tirada weerarrada iyo darnaanta.

8. Bukaannada qaba dhiigbaxa dhiigga ayaa leh dhiigbax firfircoon.

9. Waxay leedahay saameyn daaweyn oo cad oo ku saabsan chloasma.

  • Kii hore:
  • Xiga:

    • ALAABADA LA XIRIIRTA